261 related articles for article (PubMed ID: 38748660)
1. Management of childbearing with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A scoping review and expert co-creation of evidence-based clinical guidelines.
Pezaro S; Brock I; Buckley M; Callaway S; Demirdas S; Hakim A; Harris C; High Gross C; Karanfil M; Le Ray I; McGillis L; Nasar B; Russo M; Ryan L; Blagowidow N
PLoS One; 2024; 19(5):e0302401. PubMed ID: 38748660
[TBL] [Abstract][Full Text] [Related]
2. Understanding hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorders in the context of childbearing: An international qualitative study.
Pezaro DS; Pearce DG; Reinhold DE
Midwifery; 2020 Sep; 88():102749. PubMed ID: 32535291
[TBL] [Abstract][Full Text] [Related]
3. Co-Created Solutions for Perinatal Professionals and Childbearing Needs for People with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
Pearce G; Bell L; Magee P; Pezaro S
Int J Environ Res Public Health; 2023 Oct; 20(20):. PubMed ID: 37887694
[TBL] [Abstract][Full Text] [Related]
4. Childbearing with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: A Large International Survey of Outcomes and Complications.
Pearce G; Bell L; Pezaro S; Reinhold E
Int J Environ Res Public Health; 2023 Oct; 20(20):. PubMed ID: 37887695
[TBL] [Abstract][Full Text] [Related]
5. Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a scoping review.
Garreth Brittain M; Flanagan S; Foreman L; Teran-Wodzinski P
Disabil Rehabil; 2024 May; 46(10):1936-1953. PubMed ID: 37231592
[TBL] [Abstract][Full Text] [Related]
6. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
Bennett SE; Walsh N; Moss T; Palmer S
Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
Teran-Wodzinski P; Kumar A
Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
[TBL] [Abstract][Full Text] [Related]
8. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
Estrella E; Frazier PA
Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820
[TBL] [Abstract][Full Text] [Related]
9. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome.
Engelbert RH; Juul-Kristensen B; Pacey V; de Wandele I; Smeenk S; Woinarosky N; Sabo S; Scheper MC; Russek L; Simmonds JV
Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):158-167. PubMed ID: 28306230
[TBL] [Abstract][Full Text] [Related]
10. The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS).
Kucharik AH; Chang C
Clin Rev Allergy Immunol; 2020 Jun; 58(3):273-297. PubMed ID: 31267471
[TBL] [Abstract][Full Text] [Related]
11. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.
Brock I; Prendergast W; Maitland A
Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):473-481. PubMed ID: 34747107
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Physical and mechanical therapies for lower limb symptoms in children with Hypermobility Spectrum Disorder and Hypermobile Ehlers-Danlos Syndrome: a systematic review.
Peterson B; Coda A; Pacey V; Hawke F
J Foot Ankle Res; 2018; 11():59. PubMed ID: 30455744
[TBL] [Abstract][Full Text] [Related]
14. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
Thwaites PA; Gibson PR; Burgell RE
J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
[TBL] [Abstract][Full Text] [Related]
15. Functional gastrointestinal disorders are increased in joint hypermobility-related disorders with concomitant postural orthostatic tachycardia syndrome.
Tai FWD; Palsson OS; Lam CY; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
Neurogastroenterol Motil; 2020 Dec; 32(12):e13975. PubMed ID: 32803794
[TBL] [Abstract][Full Text] [Related]
16. Dysautonomia in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders is associated with exercise intolerance and cardiac atrophy.
Ruiz Maya T; Fettig V; Mehta L; Gelb BD; Kontorovich AR
Am J Med Genet A; 2021 Dec; 185(12):3754-3761. PubMed ID: 34331416
[TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial of heavy shoulder strengthening exercise in patients with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome and long-lasting shoulder complaints: study protocol for the Shoulder-MOBILEX study.
Liaghat B; Skou ST; Søndergaard J; Boyle E; Søgaard K; Juul-Kristensen B
Trials; 2020 Dec; 21(1):992. PubMed ID: 33261635
[TBL] [Abstract][Full Text] [Related]
18. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
[TBL] [Abstract][Full Text] [Related]
19. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.
Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
